Alkermes plc (ALKS) Key Metrics
ALKS valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $6.92B
- Enterprise value
- $7.98B
- P/E (TTM)
- 108.5 10-yr median 13.3
- Forward P/E
- 133.3
- PEG ratio
- 1.96
- Price / sales
- 4.1 10-yr median 3.2
- Price / book
- 3.9 10-yr median 3.6
- EV / EBITDA
- 36.6 10-yr median 10.5
- Dividend yield
- —
- Beta
- 0.27
ALKS key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsALKS valuation Price multiples at each fiscal year-end price.
ALKS returns How much profit the business earns on the capital it uses.
ALKS per-share figures Results divided by the shares outstanding at year-end.
ALKS financial health Debt, liquidity and how easily interest is covered.
ALKS efficiency & capital use Working capital cycle and where the cash goes.
ALKS valuation history
ALKS returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
ALKS debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
ALKS cash returned to shareholders
ALKS price vs earnings per share
ALKS key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $4.72B | $4.87B | $4.71B | $4.28B | $3.74B | $3.17B | $3.20B | $4.58B | $8.40B | $8.42B |
| Enterprise value | $3.47B | $4.19B | $4.31B | $4.05B | $3.62B | $2.94B | $2.96B | $4.32B | $8.09B | $8.08B |
| P/E ratio | 19.5 | 13.3 | 13.2 | — | — | — | — | — | — | — |
| Price / sales | 3.2 | 3.1 | 2.8 | 3.8 | 3.2 | 3.0 | 2.7 | 4.2 | 9.3 | 11.3 |
| Price / book | 2.6 | 3.3 | 3.9 | 4.1 | 3.4 | 3.0 | 3.0 | 3.9 | 7.0 | 7.0 |
| Price / free cash flow | 9.8 | 12.0 | 13.3 | — | 51.5 | 78.0 | — | 153.3 | — | — |
| Price / operating cash flow | 9.1 | 11.1 | 11.7 | 203.3 | 36.8 | 38.2 | 44.5 | 46.1 | 437.5 | — |
| EV / sales | 2.4 | 2.7 | 2.6 | 3.6 | 3.1 | 2.8 | 2.5 | 3.9 | 9.0 | 10.8 |
| EV / EBITDA | 10.5 | 8.5 | 8.3 | 67.7 | 20.4 | — | — | — | — | — |
| EV / free cash flow | 7.2 | 10.3 | 12.2 | — | 49.8 | 72.5 | — | 144.6 | — | — |
| Earnings yield | 5.1% | 7.5% | 7.6% | −3.7% | −1.3% | −3.5% | −6.1% | −3.0% | −1.9% | −2.5% |
| Free cash flow yield | 10.2% | 8.3% | 7.5% | −0.4% | 1.9% | 1.3% | −0.6% | 0.7% | −0.4% | −1.3% |
| Dividend yield | — | — | — | 0.0% | 0.2% | 0.0% | 0.3% | — | 0.0% | 0.0% |
| Shareholder yield (dividends + buybacks) | 0.7% | 4.1% | 0.6% | 0.5% | 0.7% | 0.3% | 0.6% | 0.4% | 0.2% | 0.2% |
| Share price at fiscal year-end | $27.98 | $28.76 | $27.74 | $26.13 | $23.26 | $19.95 | $20.40 | $29.51 | $54.73 | $55.58 |
| Per share | ||||||||||
| Revenue per share | $8.75 | $9.21 | $9.80 | $6.79 | $7.29 | $6.54 | $7.46 | $7.05 | $5.89 | $4.92 |
| Earnings per share | $1.43 | $2.17 | $2.10 | −$0.97 | −$0.30 | −$0.70 | −$1.25 | −$0.90 | −$1.03 | −$1.38 |
| Operating cash flow per share | $3.09 | $2.60 | $2.36 | $0.13 | $0.63 | $0.52 | $0.46 | $0.64 | $0.13 | −$0.42 |
| Free cash flow per share | $2.85 | $2.40 | $2.08 | −$0.11 | $0.45 | $0.26 | −$0.12 | $0.19 | −$0.21 | −$0.71 |
| Cash per share | $7.82 | $4.44 | $4.56 | $3.72 | $3.33 | $4.00 | $3.41 | $3.48 | $3.85 | $4.09 |
| Book value per share | $10.78 | $8.66 | $7.09 | $6.37 | $6.91 | $6.72 | $6.91 | $7.55 | $7.84 | $7.98 |
| Tangible book value per share | $9.79 | $8.16 | $6.58 | $5.64 | $5.88 | $5.43 | $5.36 | $5.72 | $5.57 | $5.27 |
| Dividends per share | — | — | — | $0.01 | $0.05 | $0.00 | $0.06 | — | $0.00 | $0.00 |
| Capex per share | $0.24 | $0.20 | $0.28 | $0.23 | $0.18 | $0.27 | $0.58 | $0.45 | $0.33 | $0.29 |
| Debt per share | $0.41 | $0.45 | $2.19 | $2.32 | $2.59 | $2.58 | $1.85 | $1.80 | $1.83 | $1.87 |
| Shares outstanding | 168.7M | 169.2M | 169.7M | 163.7M | 160.9M | 158.8M | 157.1M | 155.1M | 153.4M | 151.5M |
| Change in shares outstanding | −0.3% | −0.3% | +3.7% | +1.7% | +1.3% | +1.1% | +1.3% | +1.1% | +1.3% | +1.5% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 14.7% | 27.5% | 31.7% | −14.7% | −4.4% | −10.3% | −17.4% | −11.7% | −13.1% | −16.5% |
| Return on invested capital (ROIC) | 31.0% | 44.4% | 51.2% | −0.5% | 9.3% | −10.6% | −15.8% | −8.7% | −13.2% | −19.0% |
| Return on assets (ROA) | 10.5% | 17.5% | 17.4% | −7.9% | −2.4% | −5.9% | −10.8% | −7.7% | −9.0% | −11.6% |
| Return on tangible assets | 10.2% | 18.6% | 17.3% | −8.6% | −2.6% | −6.4% | −12.6% | −9.0% | −10.9% | −15.8% |
| Free cash flow margin | 32.5% | 26.0% | 21.2% | −1.5% | 6.2% | 3.9% | −1.6% | 2.7% | −3.6% | −14.4% |
| Income quality (OCF / net income) | 2.15 | 1.20 | 1.13 | — | — | — | — | — | — | — |
| Financial health | ||||||||||
| Total debt | $70.0M | $75.5M | $372.2M | $379.4M | $416.2M | $410.2M | $290.9M | $279.3M | $281.4M | $283.7M |
| Cash & short-term investments | $1.32B | $751.7M | $773.5M | $608.5M | $536.3M | $635.0M | $535.0M | $539.3M | $590.7M | $619.2M |
| Net debt | −$1.25B | −$676.1M | −$401.3M | −$229.0M | −$120.1M | −$224.9M | −$244.0M | −$260.0M | −$309.3M | −$335.5M |
| Debt / equity | 0.04 | 0.05 | 0.31 | 0.36 | 0.37 | 0.38 | 0.27 | 0.24 | 0.23 | 0.23 |
| Debt / assets | 0.03 | 0.04 | 0.17 | 0.19 | 0.21 | 0.21 | 0.16 | 0.15 | 0.16 | 0.16 |
| Net debt / EBITDA | −3.78 | −1.37 | −0.77 | −3.83 | −0.68 | — | — | — | — | — |
| Current ratio | 3.55 | 3.04 | 2.86 | 2.27 | 2.25 | 2.53 | 2.46 | 2.89 | 3.32 | 4.30 |
| Quick ratio | 3.19 | 2.65 | 2.50 | 1.91 | 1.93 | 2.25 | 2.20 | 2.63 | 3.00 | 4.01 |
| Interest coverage | 20.7 | 18.6 | 18.0 | -0.5 | 8.7 | -13.0 | -12.9 | -6.4 | -12.3 | -14.0 |
| Working capital | $1.39B | $950.2M | $965.3M | $632.6M | $590.9M | $672.7M | $570.9M | $643.5M | $674.9M | $700.6M |
| Invested capital | $569.9M | $788.8M | $801.4M | $814.7M | $992.5M | $842.1M | $841.4M | $911.3M | $893.5M | $874.0M |
| Tangible asset value | $1.65B | $1.38B | $1.12B | $923.0M | $945.7M | $862.9M | $841.9M | $887.4M | $853.8M | $798.4M |
| Net current asset value | $1.22B | $824.8M | $552.0M | $210.1M | $150.3M | $228.2M | $242.0M | $329.5M | $371.6M | $395.7M |
| Graham number | $18.64 | $20.56 | $18.28 | — | — | — | — | — | — | — |
| Graham net-net per share | $5.67 | $3.22 | $1.08 | $0.01 | −$0.34 | $0.20 | $0.41 | $1.01 | $1.42 | $1.83 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | $1.4M | $8.7M | $671,999 | $9.6M | — | $0 | $0 |
| Share buybacks (net) | $31.0M | $200.3M | $28.5M | $18.2M | $16.6M | $7.7M | $9.3M | $19.6M | $16.4M | $13.5M |
| Dividends + buybacks / free cash flow | 6.5% | 49.4% | 8.1% | — | 34.8% | 20.6% | — | 65.7% | — | — |
| Capex / revenue | 2.7% | 2.1% | 2.9% | 3.4% | 2.5% | 4.1% | 7.8% | 6.3% | 5.7% | 5.9% |
| Capex / operating cash flow | 7.8% | 7.6% | 12.0% | 181.8% | 28.5% | 51.0% | 126.2% | 69.9% | 267.3% | — |
| Capex / depreciation | 1.49 | 1.17 | 0.64 | 0.49 | 0.37 | 0.52 | 1.13 | 0.67 | 0.52 | 0.46 |
| Stock-based compensation / revenue | 6.7% | 6.2% | 6.1% | 8.5% | 7.5% | 8.7% | 8.6% | 9.6% | 9.3% | 12.7% |
| R&D / revenue | 22.0% | 15.7% | 16.3% | 24.5% | 24.8% | 38.0% | 43.8% | 38.9% | 45.7% | 51.9% |
| SG&A / revenue | 48.4% | 41.4% | 41.5% | 53.1% | 46.8% | 51.9% | 51.2% | 48.1% | 46.7% | 50.2% |
| Efficiency | ||||||||||
| Days sales outstanding | 89.5 | 84.7 | 69.1 | 102.3 | 95.8 | 97.5 | 88.2 | 89.1 | 85.8 | 84.8 |
| Days of inventory on hand | 352.6 | 274.7 | 265.3 | 277.6 | 255.3 | 232.9 | 194.3 | 189.8 | 184.3 | 140.1 |
| Days payables outstanding | 142.7 | 82.8 | 71.0 | 74.1 | 94.1 | 102.6 | 95.1 | 98.6 | 120.1 | 115.6 |
| Cash conversion cycle (days) | 299.3 | 276.6 | 263.4 | 305.9 | 257.0 | 227.7 | 187.3 | 180.3 | 150.0 | 109.3 |
| Receivables turnover | 4.08 | 4.31 | 5.28 | 3.57 | 3.81 | 3.74 | 4.14 | 4.10 | 4.25 | 4.30 |
| Payables turnover | 2.56 | 4.41 | 5.14 | 4.92 | 3.88 | 3.56 | 3.84 | 3.70 | 3.04 | 3.16 |
| Inventory turnover | 1.04 | 1.33 | 1.38 | 1.31 | 1.43 | 1.57 | 1.88 | 1.92 | 1.98 | 2.61 |
| Asset turnover | 0.64 | 0.74 | 0.81 | 0.56 | 0.59 | 0.55 | 0.65 | 0.60 | 0.51 | 0.42 |
| Average receivables | $361.8M | $361.4M | $315.0M | $311.7M | $308.1M | $277.5M | $283.0M | $267.0M | $212.3M | $173.3M |
| Average payables | $76.8M | $55.6M | $49.2M | $44.3M | $50.9M | $50.1M | $47.0M | $47.6M | $50.9M | $41.8M |
| Average inventory | $189.8M | $184.6M | $183.9M | $165.9M | $138.0M | $113.8M | $96.0M | $91.7M | $78.1M | $50.7M |
| Intangibles / total assets | 6.6% | 4.1% | 4.0% | 6.1% | 8.2% | 10.5% | 13.5% | 15.6% | 19.4% | 23.8% |
Computed from ALKS's annual financial statements (latest annual report filed February 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
ALKS valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Alkermes traded at 19.5 times earnings, against a 10-year median of 13.3. Based on the latest twelve months, the trailing P/E is 108.5 and the forward P/E is 133.3. Alkermes earned a return on equity of 14.7% and a return on invested capital of 31.0% in fiscal 2025. It ended the year with $70.0 million of debt and $1.3 billion in cash and short-term investments, a net cash position of $1.2 billion. It returned $31.0 million to shareholders: $0 in dividends and $31.0 million in share buybacks, 6% of free cash flow. The share count rose 11.4% from 151.5M to 168.7M over 9 years.
See the ALKS income statement, the ALKS chart for price history, or the ALKS stock overview for the latest quote and news.
ALKS key metrics FAQ
What is Alkermes's P/E ratio?
Alkermes's trailing P/E ratio is 108.5 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 133.3. At the end of fiscal 2025 it was 19.5, compared with a 10-year median of 13.3.
What is Alkermes's EV/EBITDA?
Alkermes's enterprise value was 10.5 times EBITDA at the end of fiscal 2025 (enterprise value $3.5 billion, EBITDA $330.9 million); the current EV/EBITDA is 36.6.
What is Alkermes's return on equity?
Alkermes's return on equity (ROE) was 14.7% in fiscal 2025: net income of $241.7 million on average shareholders' equity of $1.6 billion.
What is Alkermes's ROIC?
Alkermes's return on invested capital was 31.0% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Alkermes have?
Alkermes had total debt of $70.0 million at the end of fiscal 2025, a debt-to-equity ratio of 0.04 and more cash than debt.
Does Alkermes buy back its shares?
Yes. Alkermes spent $31.0 million on net share repurchases in fiscal 2025 Shares outstanding changed −0.3% over the year, to 168.7M..
What is Alkermes's free cash flow yield?
Alkermes generated $480.3 million of free cash flow in fiscal 2025, a free cash flow yield of 10.2% on its market value at year-end ($4.7 billion).
What is Alkermes's current ratio?
Alkermes's current ratio was 3.55 at the end of fiscal 2025: current assets were 3.55 times current liabilities.